These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6112233)

  • 1. Antibodies to insulin, pancreatic polypeptide, glucagon, and somatostatin in insulin-treated diabetics.
    Fitz-Patrick D; Patel YC
    J Clin Endocrinol Metab; 1981 May; 52(5):948-52. PubMed ID: 6112233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating antibodies in diabetics treated with conventional and purified insulins.
    Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
    S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to pancreatic hormones in diabetics treated before 1964 and after 1974.
    Meryn S; Spigland I; Bauman WA
    Clin Immunol Immunopathol; 1986 Aug; 40(2):291-7. PubMed ID: 2872983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin, pancreatic polypeptide, and glucagon antibodies in insulin-dependent diabetes mellitus.
    Asplin CM; Hollander P; Pecoraro RE; Brodsky J; Palmer JP
    Diabetes Care; 1981; 4(3):337-42. PubMed ID: 7047110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic polypeptide and other pancreatic hormones in spontaneously diabetic BB/W rats.
    Tomita T; Doull V; Fredrickson D; Pollock G
    Pancreas; 1990 Nov; 5(6):658-67. PubMed ID: 1980735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity in diabetics induced by hormonal contaminants of insulin.
    Bloom SR; Adrian TE; Barnes AJ; Polak JM
    Lancet; 1979 Jan; 1(8106):14-7. PubMed ID: 83463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.
    Kurtz AB; Matthews JA; Mustaffa BE; Daggett PR; Nabarro JD
    Diabetologia; 1980; 18(2):147-50. PubMed ID: 6988274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal development of the human pancreatic islets. Immunocytochemical identification of insulin-, glucagon-, somatostatin- and pancreatic polypeptide-containing cells.
    Bocian-Sobkowska J; Zabel M; Woźniak W; Surdyk-Zasada J
    Folia Histochem Cytobiol; 1997; 35(3):151-4. PubMed ID: 9276343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal studies in a patient with PP-producing tumors.
    Bordi C; Sivelli R; Lampugnani R; Zanella E; Fajans SS
    Horm Metab Res; 1985 Sep; 17(9):467-70. PubMed ID: 3899891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-localization of neuroendocrine hormones in the human fetal pancreas.
    Portela-Gomes GM; Johansson H; Olding L; Grimelius L
    Eur J Endocrinol; 1999 Nov; 141(5):526-33. PubMed ID: 10576771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-insulin, proinsulin, pancreatic polypeptide, glucagon and somatostatin antibodies in patients with insulin-dependent diabetes mellitus treated with conventional insulin preparations].
    Dominiak K; Gembal M; Horoszek-Maziarz S; Wójcikowski C
    Endokrynol Pol; 1987; 38(4):281-90. PubMed ID: 2900755
    [No Abstract]   [Full Text] [Related]  

  • 12. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
    Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentrations of insulin binding antibodies in blood serum samples from newborn infants delivered by diabetic mothers treated with insulin].
    Rogala H; Janczewska E; Dziewulska T
    Ginekol Pol; 1978 Oct; 49(10):885-91. PubMed ID: 720904
    [No Abstract]   [Full Text] [Related]  

  • 16. Fetal and maternal plasma levels of immunoreactive somatostatin at delivery: evidence for its increase in the umbilical artery and its arterio-venous gradient in the feto-placental circulation.
    Saito H; Saito S; Sano T; Hosoi E; Saito H
    J Clin Endocrinol Metab; 1983 Mar; 56(3):567-71. PubMed ID: 6130103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high molecular weight form of pancreatic polypeptide was present in USP insulin and is absent in a more recent insulin preparation.
    Bauman WA; Meryn S
    J Pharm Pharmacol; 1987 Jul; 39(7):549-50. PubMed ID: 2886625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats.
    Adeghate E
    Neuropeptides; 1999 Jun; 33(3):227-35. PubMed ID: 10657496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pancreatic somatostatin content in spontaneously diabetic mice, as determined by radioimmunoassay and immunohistochemical methods.
    Makino H; Matsushima Y; Kanatsuka A; Yamamoto M; Kumagai A; Nishimura M
    Endocrinology; 1979 Jan; 104(1):243-7. PubMed ID: 376284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.